Lung Cancer Clinical Trial
— TELErpOfficial title:
Feasibility of an Eight-week Telerehabilitation Program for Patients With Unresectable Thoracic Neoplasia Receiving Chemotherapy
Exercise-based rehabilitation improves physical function, fatigue and quality of life in
patients with thoracic neoplasia. Consequently, the need for rehabilitation across the
continuum of care in oncology is growing rapidly. However, the implementation of this type
of intervention is limited because of many barriers such as patients' symptoms and poor
accessibility to programs. In this context, healthcare systems should develop and implement
new approaches to dispense these services. Consequently, telerehabilitation is a promising
strategy to improve access and adherence to rehabilitation.
OBJECTIVES To investigate the feasibility, adherence and satisfaction of a home-based
telerehabilitation program (TELERP) with real-time physiological parameters acquisition in
patients with unresectable thoracic neoplasia receiving chemotherapy and to explore its
effects on patients' functional capacity.
METHODS Five patients receiving chemotherapy followed an 8-week TELERP using real-time
monitoring combined with interactive exercises. The TELERP included supervised (15) and
unsupervised (9) strengthening and cardiovascular exercise sessions at a rate of 3
sessions/week. The feasibility of the TELERP, adverse outcomes, technical issues, program
adherence and satisfaction were analysed. Prior to and after the program, a six-minute
walking test (6MWT), a timed up and go (TUG) and a timed stair test (TST) were done to
assess functional capacity
Status | Active, not recruiting |
Enrollment | 5 |
Est. completion date | July 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patients had to have an ECOG functional status of 0 (Asymptomatic) or 1 (Symptomatic but completely ambulatory); - Have a sufficient understanding of verbal and written French instructions - Live in a geographic region served by a high speed Internet connection. Exclusion Criteria: - oxygen pulsed saturation (SpO2) <80% during the cardiopulmonary exercise test - contraindications to exercise testing according to the American Thoracic Society and American College of Chest Physicians Exercise Testing Guidelines - cerebral or bone metastasis - a history of significant cardiovascular disease, hypertension, diabetes or musculoskeletal concerns that might limit their ability to perform active exercises - severe psychiatric illness compromising adherence to the rehabilitation training routine. |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Canada | CRIUCPQ | Quebec |
Lead Sponsor | Collaborator |
---|---|
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of adverse events during the 8-week telerehabilitation program | Along the 8-week program | Yes | |
Primary | Adherence of the participants to the 8-week telerehabilitation program. | Adherence was defined as the number of sessions done over the prescribed sessions (supervised and unsupervised) and as percentage of time spent within the target heart rate range (intensities) throughout the cardiovascular exercise sessions | Along the 8-week program | No |
Primary | Participants satisfaction with the telerehabilitation platform with the Québec User Evaluation of Satisfaction with Assistive Technology questionnaire (QUEST 2.0) | The satisfaction of the patients was evaluated using a questionnaire adapted from the Québec User Evaluation of Satisfaction with Assistive Technology questionnaire (QUEST 2.0) that calculates both satisfaction scores for technological aspects and services. It consists of 12 items rated on a scale from 1 to 5 (1: not satisfied at all to 5: very satisfied). | At the end of the 8-week telerehabilitation program | No |
Primary | User satisfaction with health services received with the French version of the Health Care Satisfaction Questionnaire | To assess more specifically the user satisfaction with health services received, we used the French version of the Health Care Satisfaction Questionnaire. This is a 26-item questionnaire answered on a four-point Likert scale, where ''1'' represents ''not at all satisfied'' and ''4'' represents ''highly satisfied". The total score is calculated in percentage and can be computed as the mean overall satisfaction divided in three domains: i) relationship with the professional, ii) delivery of services and iii) organization of services. Higher scores indicate a higher level of satisfaction. | At the end of the 8-week telerehabilitation program | No |
Secondary | Cardiopulmonary maximal exercise test (CPET) | At baseline and following the 8-week program | No | |
Secondary | Constant workrate cycle exercise test at 80% of the maximal capacity of the patient | At baseline and following the 8-week program | No | |
Secondary | Isokinetic quadriceps muscle functions | Quadriceps muscle function (strength and endurance) was assessed during an isokinetic endurance test performed at a rate of 30 repetitions at 90°/sec of angular velocity (Biodex, system pro 4, Biodex Medical System, 20 Ramsay Road, Shirley, New York ) | At baseline and following the 8-week program | No |
Secondary | Lean body mass | Lean body mass (in Kg) were measured by bioelectrical impedance analysis (TBF-300WA Tanita, Arlington Heights, IL, USA) | At baseline and following the 8-week program | No |
Secondary | Fat body mass | Fat body mass (in Kg) were measured by bioelectrical impedance analysis (TBF-300WA Tanita, Arlington Heights, IL, USA) | At baseline and following the 8-week program | No |
Secondary | Weight | Weight (in Kg) of the patient | At baseline and following the 8-week program | No |
Secondary | Height | Height (in meters) of the patient | At baseline and following the 8-week program | No |
Secondary | Timed up and go test | At baseline and following the 8-week program | No | |
Secondary | Timed stairs test | At baseline and following the 8-week program | No | |
Secondary | Distance achieved during the 6 minutes walking test | At baseline and following the 8-week program | No | |
Secondary | Cancer specific quality of life with the self-reported European Organization for Research and Treatment of Cancer Quality of Life Questionnaire questionnaire | The cancer related quality of life was assessed using the self-reported European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-30) including the lung cancer specific questionnaire QLQ-LC13 | At baseline and following the 8-week program | No |
Secondary | Anxiety and depression with the Hospital Anxiety and Depression Scale questionnaire | The French Canadian version of the Hospital Anxiety and Depression Scale (HADS) was used to identify patients suffering of anxiety disorders or depression | At baseline and following the 8-week program | No |
Secondary | Nutritional status with the mini-nutritional assessment | At baseline and following the 8-week program | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|